# Skin Tumor Biomarkers by Mass Spectrometry Imaging

> **NCT06227416** · NA · UNKNOWN · sponsor: **Bispebjerg Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Skin Cancer
- Squamous Cell Carcinoma
- Basal Cell Carcinoma
- Non-melanoma Skin Cancer

## Interventions

- **OTHER:** Biopsy

## Key facts

- **NCT ID:** NCT06227416
- **Lead sponsor:** Bispebjerg Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-15
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06227416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06227416, "Skin Tumor Biomarkers by Mass Spectrometry Imaging". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06227416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*